icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
In vitro Assessment of Drug-Drug Interaction Potential of Boceprevir As an Inhibitor and Inducer of Drug Metabolizing Enzymes and Transporters
 
 
  Reported by Jules Levin
AASLD Nov 5-8 2011 SF
 
Xiaoyan Chu, Xiaoxin Cai, Dan Cui, Raymond Evers, Mitchell D Green, Anima Ghosal, Cuyue Tang, Yuhsin Kuo, Yuexia Liang, Cheri M Maciolek,Jairam Palamanda, Grace Chan, Jocelyn Yabut, Thomayant Prueksaritanont Merck, Whitehouse Station, NJ USA
 
AASLD: Concomitant Medication Use (drug interactions) in Patients with Hepatitis C Genotype 1 Treated with Boceprevir Combination Therapy - (11/15/11)

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif

AASLD14.gif

AASLD15.gif

AASLD16.gif

AASLD17.gif